O15530 (PDPK1_HUMAN) Homo sapiens (Human)
3-phosphoinositide-dependent protein kinase 1 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
70 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of PDK1 in complex with ATP and PIFtide |
Heteromer Q16513; | 99.3 | 1×ATP; 2×GOL; | |||
| Crystal structure of WDR5 in complex with the WIN peptide of PDPK1 |
Heteromer P61964; | 100 | ||||
| High resolution crystal structure of the human PDK1 catalytic domain | homo-2-mer | 100.0 | 16×GOL; 10×SO4; 2×ATP; | |||
| Crystal structure of PDK1 in complex with a pyrazoloquinazoline inhibitor | homo-2-mer | 100.0 | 2×CKG; 12×GOL; 12×SO4; | |||
| Crystal structure of PDK1 in complex with a pyrazoloquinazoline inhibitor | homo-2-mer | 99.64 | 2×MH4; 8×GOL; 6×SO4; | |||
| Human PDK1 Kinase Domain in Complex with Allosteric Compound PS210 Bound to the PIF-Pocket | monomer | 99.3 | 1×ATP; 1×21O; 2×DMS; 1×MN; 2×NA; 3×CL; | |||
| Human PDK1 kinase domain in complex with Valsartan | monomer | 99.31 | 3×U35; 1×GOL; | |||
| Crystal structure of PDK1 in complex with ATP and the PIF-pocket ligand RF4 | monomer | 99.31 | 1×ATP; 2×RF4; 3×GOL; | |||
| Crystal structure of PDK1 in complex with ATP and the PIF-pocket ligand RS2 | monomer | 99.31 | 4×GOL; 1×ATP; 1×R2S; | |||
| Structure of human PDK1 kinase domain in complex with staurosporine | monomer | 100.0 | 3×GOL; 5×SO4; 1×STU; | |||
| Structure of human PDK1 kinase domain in complex with BIM-8 | monomer | 100.0 | 8×GOL; 4×SO4; 1×BI8; | |||
| DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS | monomer | 100.0 | 1×63L; 1×SO4; | |||
| DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS | monomer | 100.0 | 2×SO4; 1×62O; | |||
| Crystal structure of an extender (SPD28345)-modified human PDK1 complex 2 | monomer | 99.29 | 1×SYP; | |||
| Structure of human PDK1 kinase domain in complex with LY333531 | monomer | 100.0 | 8×GOL; 7×SO4; 1×LY4; | |||
| Structure of PDK1-S241A mutant kinase domain | monomer | 99.65 | 7×GOL; 7×SO4; 1×ATP; | |||
| Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 1,1-Dimethylethyl {(3R,6S)-1-[2-amino… | monomer | 100.0 | 1×3Q5; 1×SO4; 2×GOL; | |||
| phosphoinositide-dependent kinase-1 (PDK1) with lead compound | monomer | 100.0 | 4×GOL; 6×SO4; 1×JMZ; | |||
| Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 1,1-Dimethylethyl{(3R,5R)-1-[2-amino-… | monomer | 100.0 | 1×3Q6; 1×SO4; | |||
| Discovery of a Novel, Potent and Selective Inhibitor of 3-Phosphoinositide Dependent Kinase (PDK1) | monomer | 100.0 | 1×3RW; 3×GOL; 7×SO4; | |||
| DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS | monomer | 100.0 | 1×63E; 4×SO4; | |||
| Human PDK1 Kinase Domain in Complex with Allosteric Compound PSE10 Bound to the PIF-Pocket | monomer | 99.3 | 1×ATP; 1×78W; 1×DMS; 1×DTD; 1×CL; | |||
| Human PDK1 Kinase Domain in Complex with Allosteric Compound 7 Bound to the PIF-Pocket | monomer | 99.3 | 1×ATP; 1×SVQ; 1×DTD; 1×DMS; 3×NA; | |||
| Structure of human PDK1 kinase domain in complex with BIM-2 | monomer | 100.0 | 4×GOL; 1×BI2; 4×SO4; | |||
| Discovery of a Novel, Potent and Selective Inhibitor of 3-Phosphoinositide Dependent Kinase (PDK1) | monomer | 100.0 | 4×GOL; 6×SO4; 1×ABQ; | |||
| Structure of human PDK1 kinase domain in complex with BIM-1 | monomer | 100.0 | 7×GOL; 3×SO4; 1×BI1; | |||
| Structure of human PDK1 kinase domain in complex with UCN-01 | monomer | 100.0 | 6×GOL; 5×SO4; 1×UCN; | |||
| PDK1 in complex with inhibitor MP6 | monomer | 100.0 | 1×MP6; | |||
| Novel Isoquinolone PDK1 Inhibitors Discovered through Fragment-Based Lead Discovery | monomer | 100.0 | 1×3S1; 4×SO4; 2×GOL; | |||
| Human PDK1 Kinase Domain in Complex with Compound PS653 Bound to the ATP-Binding Site | monomer | 99.3 | 1×537; 1×DTD; 3×DMS; | |||
| Crystal structure of PDK1 in complex with ATP and the PIF-pocket ligand RS1 | monomer | 99.3 | 2×GOL; 1×ATP; 1×R1S; 1×EPE; | |||
| Structure of human PDK1 kinase domain in complex with BIM-3 | monomer | 100.0 | 8×GOL; 5×SO4; 1×BI3; | |||
| phosphoinositide-dependent kinase-1 (PDK1) with fragment11 | monomer | 100.0 | 4×GOL; 10×SO4; 1×JOZ; | |||
| Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with (2R,5S)-1-[2-Amino-6-(3-amino-1H-inda… | monomer | 100.0 | 5×GOL; 5×SO4; 1×3Q4; | |||
| PDK1 mutant bound to allosteric disulfide fragment activator 2A2 | monomer | 99.64 | 1×2A2; 1×BI4; | |||
| phosphoinositide-dependent kinase-1 (PDK1) with fragment17 | monomer | 100.0 | 4×GOL; 3×SO4; 1×JPZ; | |||
| CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 3-{5-[2-Oxo-5-ureido-… | monomer | 100.0 | 3×SO4; 1×464; 8×GOL; | |||
| CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) {2-Oxo-3-[1-(1H-pyrro… | monomer | 100.0 | 2×SO4; 1×517; 4×GOL; | |||
| Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)amino]phenyl]amino]-4-pyrimidin… | monomer | 100.0 | 1×SO4; 1×CL; 1×LI8; 3×GOL; | |||
| Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 4-[2-Amino-6-(3-amino-1H-indazol-6-yl… | monomer | 100.0 | 4×GOL; 6×SO4; 1×3Q3; | |||
| Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 6-{2-Amino-6-[(3R)-3-methyl-4-morphol… | monomer | 100.0 | 5×GOL; 6×SO4; 1×3Q2; | |||
| CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-Hydroxy-3-[1-(1H-py… | monomer | 100.0 | 2×SO4; 1×39Z; 3×GOL; | |||
| Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 6-[2-Amino-6-(4-morpholinyl)-4-pyrimi… | monomer | 100.0 | 4×GOL; 5×SO4; 1×3Q1; | |||
| Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 6-(3-Amino-1H-indazol-6-yl)-N4-ethyl-… | monomer | 100.0 | 4×GOL; 3×SO4; 1×3Q0; | |||
| phosphoinositide-dependent kinase-1 (PDK1) with fragment8 | monomer | 100.0 | 4×GOL; 1×JNZ; 3×SO4; | |||
| Human PDK1-PKCzeta Kinase Chimera | monomer | 96.79 | 1×ATP; 1×DTD; 1×NA; | |||
| Human PDK1 Kinase Domain in Complex with Adenosine Bound to the ATP-Binding Site | monomer | 99.3 | 1×DTD; 1×ADN; 1×CL; | |||
| Human PDK1 Kinase Domain in Complex with Allosteric Compound PS182 Bound to the PIF-Pocket | monomer | 99.3 | 1×ATP; 1×MJF; 1×DMS; 2×MG; 1×DTD; | |||
| PDK1 in complex with inhibitor MP7 | monomer | 100.0 | 1×MP7; | |||
| Human PDK1 Kinase Domain in Complex with Allosteric Activator PS171 Bound to the PIF-Pocket | monomer | 99.3 | 1×ATP; 2×AZ7; 1×MG; 5×CL; | |||
| Crystal structure of Human PDK1 kinase domain in complex with an allosteric activator bound to the … | monomer | 99.3 | 1×ATP; 1×P47; 2×EPE; | |||
| Human PDK1 Kinase Domain in Complex with Allosteric Activator PS114 Bound to the PIF-Pocket | monomer | 99.3 | 1×ATP; 1×A06; 1×DMS; 8×CL; | |||
| PDK-1 in complex with the inhibitor Compound-8i | monomer | 100.0 | 1×8I1; | |||
| PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8 | monomer | 99.65 | 1×1F8; 1×CL; | |||
| Phosphoinositide-dependent protein kinase 1 (PDK-1) in complex with compound 9 | monomer | 100.0 | 1×9BD; | |||
| PDK1 in complex with Compound 8h | monomer | 100.0 | 1×8H1; 1×SO4; | |||
| Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket | monomer | 99.28 | 1×ATP; | |||
| Crystal Structure of the Phosphoinositide-dependent Kinase-1 (PDK-1)Catalytic Domain bound to a dib… | monomer | 100.0 | 1×SO4; 1×253; | |||
| Human PDK1 Kinase Domain in Complex with Adenine Bound to the ATP-Binding Site | monomer | 99.3 | 1×ADE; 1×DTD; | |||
| Human PDK1-PKCiota Kinase Chimera in Complex with Allosteric Compound PS267 Bound to the PIF-Pocket | monomer | 96.48 | 1×S26; 1×DTT; 2×DMS; 1×ATP; | |||
| PDK1 in complex with DFG-OUT inhibitor xxx | monomer | 99.28 | 1×MP7; | |||
| Human PDK1-PKCzeta Kinase Chimera in Complex with Allosteric Compound PS315 Bound to the PIF-Pocket | monomer | 96.48 | 1×ATP; 1×31S; 1×DMS; 1×DTD; | |||
| Crystal structure of a mutant of human PDK1 Kinase domain in complex with ATP | monomer | 99.29 | 1×ATP; | |||
| DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS | monomer | 100.0 | 2×SO4; 1×61Y; | |||
| PDK1 mutant bound to allosteric disulfide fragment activator JS30 | monomer | 99.64 | 1×J30; 1×BI4; 8×SO4; 2×CL; | |||
| Rapid preparation of triazolyl substituted NH-heterocyclic kinase inhibitors via one-pot Sonogashir… | monomer | 99.29 | 1×3RC; | |||
| Crystal Structure of the PDK1 Pleckstrin Homology (PH) domain | monomer | 100 | 1×GOL; 3×SO4; | |||
| Crystal Structure of the PDK1 Pleckstrin Homology (PH) domain bound to DiC4-phosphatidylinositol (3… | monomer | 100 | 1×4PT; | |||
| Crystal Structure of the PDK1 Pleckstrin Homology (PH) domain bound to Inositol (1,3,4,5)-tetrakisp… | monomer | 100 | 1×GOL; 1×AU; 1×4IP; | |||
| Structure of the PDK1 PH domain K465E mutant | monomer | 99.29 | 1×GOL; 1×SO4; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3rwq.2.B | monomer | 0.85 | 1×3RW; | 100.00 | ||
| 4mvf.1.A | monomer | 0.54 | 33.15 | |||
8 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 2biy.1.A | monomer | 0.86 | 1×ATP; | 99.68 | ||
| Isoform 2 | 4mvf.1.A | monomer | 0.54 | 33.24 | |||
| Isoform 3 | 5ho7.1.A | monomer | 0.84 | 1×63L; | 100.00 | ||
| Isoform 3 | 4mvf.1.A | monomer | 0.56 | 32.84 | |||
| Isoform 4 | 1w1h.2.A | monomer | 0.82 | 100.00 | |||
| Isoform 4 | 3rwq.2.B | monomer | 0.71 | 81.94 | |||
| Isoform 5 | 2biy.1.A | monomer | 0.87 | 1×ATP; | 99.68 | ||
| Isoform 5 | 4mvf.1.A | monomer | 0.53 | 33.15 | |||